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Abstract
Background: Overuse of unnecessary care is widespread around the world. This so-called low-
value care provides no beneﬁt for the patient, wastes resources and can cause harm. The concept
of low-value care is broad and there are different reasons for care to be of low-value. Hence, differ-
ent strategies might be necessary to reduce it and awareness of this may help in designing a de-
implementation strategy. Based on a literature scan and discussions with experts, we identiﬁed
three types of low-value care.
Results: The type ineffective care is proven ineffective, such as antibiotics for a viral infection.
Inefﬁcient care is in essence effective, but is of low-value through inefﬁcient provision or inappro-
priate intensity, such as chronic benzodiazepine use. Unwanted care is in essence appropriate for
the clinical condition it targets, but is low-value since it does not ﬁt the patients’ preferences, such
as a treatment aimed to cure a patient that prefers palliative care. In this paper, we argue that
these three types differ in their most promising strategy for de-implementation and that our typ-
ology gives direction in choosing whether to limit, lean or listen.
Conclusion: We developed a typology that provides insight in the different reasons for care to be
of low-value. We believe that this typology is helpful in designing a tailor-made strategy for redu-
cing low-value care.
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Introduction
Overuse of unnecessary care is widespread around the world and
especially prevalent in high-income countries [1, 2]. Experts estimate
that ~10–30% of all healthcare practices have little or no beneﬁt to
the patient [3, 4]. Apart from wasting limited resources, these so-
called low-value care practices may cause physical, psychological
and ﬁnancial harm to patients [1]. For example, an unnecessary CT-
scan exposes the body to harmful radiation and overuse of antibio-
tics contributes to antibiotic resistance at population level. Berwick
and Hackbarth estimated that between $107 billion and $389 bil-
lion was wasted on low-value care in the USA in 2011 [5]. Reducing
low-value care is therefore a step towards the triple aim in
healthcare: improving the experience of care and the health of popu-
lations, and reducing its costs [6]. Hence, there is an increasing num-
ber of initiatives around the world to identify and reduce low-value
care [1, 7], the largest of them being Choosing Wisely [8].
The concept of low-value care is broad and listed low-value ser-
vices vary, ranging from routine transthoracic echocardiograms [9]
to the chronic use of benzodiazepines [10] and curative treatment
for patients that prefer palliative care [11]. These cases of low-value
care have different contexts and different reasons for being of low-
value, enable different perspectives by diverse stakeholders and
require different strategies for de-implementation. Just as in imple-
mentation [4], one size does not ﬁt all in de-implementation and
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tailoring your strategy to the context of the low-value care practice
is important. We are convinced that being aware of the reason for
care to be of low-value is important in selecting a strategy.
To the best of our knowledge, there is no literature that reports
taking this into account in developing a strategy for reducing low-
value care. The aim of this paper is to introduce a typology of low-
value care that creates awareness of the wide range of low-value
care and provides direction in how to reduce it.
What is low-value care?
What low-value care entails depends on the deﬁnition of value.
Literature shows different deﬁnitions for low-value care that contain
several elements [12–18]; low-value care is care: that provides min-
imal or no health beneﬁt; which beneﬁt does not weigh up to the
harms; which beneﬁt does not weigh up to the costs; that is less
cost-effective than alternative care, and that does not ﬁt the prefer-
ences of the patient. There is no deﬁnition that encompasses all ele-
ments. Therefore, we will use the following deﬁnition of low-value
care: ‘care that is unlikely to beneﬁt the patient given the harms,
cost, available alternatives, or preferences of the patient’. This deﬁn-
ition includes care that is low-value from both the patients’ and soci-
etal perspective.
Low-value care is also being addressed in other terms, such as
overuse, which is often mentioned next to underuse (failing to pro-
vide care when it would have produced a favorable outcome) and
misuse (selecting high-value care but not delivering to its full poten-
tial due to preventable complications) [12]. The related terms over-
treatment and overtesting indicate the inappropriate delivery of
particular types of services [1]. Another related term, overdiagnosis,
occurs when people without symptoms are diagnosed with a disease
that ultimately will not cause symptoms or early death [19].
In this paper, we focus on care that is proven to be of low-value
and of which the physician can predict it is of low-value at the time
of deciding to deliver the speciﬁc care practice. We do not focus on
care that has unknown effectiveness and care that appeared to be of
no value after it had been used. However, determining if a care prac-
tice is unlikely to beneﬁt the patient on beforehand can be hard.
Often there is a lack of sound scientiﬁc evidence, for example,
because studies lack an appropriate comparator or relevant and
long-term outcome measures [20]. Drugs and medical devices can be
authorized for the market based on this weak evidence. And even
when there is sufﬁcient evidence, using it to predict for an individual
patient whether a practice is of low-value or not could also be hard.
Current typologies
We reviewed scientiﬁc literature on low-value care of the past 10
years and found three papers that describe a typology or framework
with different types of low-value care related to the reason for being
low-value [13, 21, 22]. We searched PubMed on 28 March 2017
with the following search strategy and included articles from 01
January 2007: (low-value care[tiab] OR lower-value care[tiab] OR
unnecessary care[tiab] OR overuse[tiab] OR overdiagnosis[tiab] OR
Medical Overuse[Mesh]) AND (framework[tiab] OR types[tiab]
OR typology[tiab] OR classiﬁcation[tiab]). E.W.V. and S.A.vD. screened
all articles independently and discussed for ﬁnal inclusion. See Fig. 1
for a ﬂowchart of this process. We included articles that describe dif-
ferent types of low-value care related to the reason for being low-
value. We excluded papers without typologies and papers with
typologies that did not provide insight into the reason for being
low-value, such as type of care (diagnostics, treatment or preven-
tion), costs and effects of care, and barriers and facilitators for redu-
cing low-value care. Wennberg identiﬁed three types of unwarranted
variations in care; effective care, preference-sensitive care and
supply-sensitive care [23]. However, these unwarranted variations
include both overuse of low-value care and underuse of high-value
care, while we focus on care that is proven of low-value.
The found typologies describe several reasons for care to be of
low-value, such as when care ‘occurs too frequently’ [13], ‘is not
clinically indicated for the patient’s symptom or diagnosis’ [13], ‘is
delivered in the wrong doses or duration’ [21], ‘has a cheaper,
equally effective alternative’ [21] or ‘has a close beneﬁt-risk balance
in mild cases’ [22].
The typologies all include categories focused on the value of a
service from a medical perspective. However, none of the typologies
include the option of care being low-value due to the patients’ pre-
ferences. Since patient preferences are recognized in the deﬁnitions
of low-value care and evidence based practice, and are recognized
by Choosing wisely as being an important component of avoiding
overuse [24], the current typologies do not represent the full spec-
trum of low-value care. In addition, two typologies include categor-
ies that do not match our deﬁnition of low-value care [21, 22], We
would categorize ‘Not receiving a medicine that is clinically needed’
as underuse, and ‘canceled procedures’ and ‘potentially cosmetic
interventions’ are not necessarily low-value according to our deﬁn-
ition. Some categories within the typologies have the same under-
lying cause for being low-value. For example, the categories ‘services
that are not matched to the patient’s risk of disease’ and ‘when the
patient has contraindications that increase the risk of the service’
both represent care whose beneﬁts do not outweigh the risks. Lastly,
the typologies do not facilitate the selection of a promising strategy
for reducing low-value care. Each typology offers insight in low-
value care, but they do not comprise the full spectrum of low-value
care and they do not give direction to reducing low-value care.
Therefore, we developed a new typology.
Figure 1 Flowchart literature scan.
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Introduction of a new typology
Based on our deﬁnition of low-value care and in collaboration with
ﬁve clinicians and researchers with expertize on low-value care or
implementation, we created three types of low-value care related to
their reason for being of low-value. Figure 2 shows our typology.
The category ineffective care is of low-value from a medical perspec-
tive. It includes care that is proven (cost)ineffective for a certain con-
dition or which beneﬁt does not weigh up to the harms according to
scientiﬁc standards, for the majority of the population or a well-
deﬁned subgroup. Examples are shaving before an operation, the
use of antibiotics in children with upper respiratory tract infections
and routine echocardiography for asymptomatic patients.
The category inefﬁcient care is of low-value from a societal per-
spective. It includes care that is in essence effective for the targeted
condition, but becomes of low-value through inefﬁcient provision or
inappropriate high intensity or duration. Examples of inefﬁcient
provision are duplication of diagnostic tests and removing stitches in
hospital instead of general practice. Examples of inappropriate
intensity are routine use of ‘last-resort’ antibiotics, chronic benzodi-
azepine use and prolonged catheterization.
The category unwanted care, lastly, is of low-value from the
patients’ perspective. Like ‘inefﬁcient care’ it is in essence effective
for the targeted condition, but becomes low-value because it does
not solve the individual patients’ problem or does not ﬁt the individ-
ual patient’s preferences. Examples are vaccines and blood transfu-
sions for patients with certain religious beliefs, chemotherapy for a
patient that prefers palliative care, or surgery while the patient pre-
fers conservative treatment. This category is probably the least well-
known and least well-studied type of low-value care, because it can
only be identiﬁed and measured by assessing the patient’s values.
An example to illustrate this typology is the use of an magnetic
resonance imaging (MRI) scan in a patient with a lumbal hernia. An
MRI scan may have been low-value because the scan was not indi-
cated (ineffective); because the scan had been done before (inefﬁ-
cient) or because the outcome of the scan would not alter treatment
anyway: the patient prefers conservative treatment over an oper-
ation (unwanted). Logically, the strategy to reduce unnecessary MRI
scans in each of the three options differs.
Using the typology in reducing low-value care
We argue that these three types differ in their most promising strat-
egy for de-implementation. For the category ‘Ineffective care’, it can
be clearly determined which patients do and do not need to receive
certain care. This enables macro-level strategies enacted by the gov-
ernment or national institutes with consequences for the whole com-
munity, such as market withdrawal or exclusion from the beneﬁt
package, which make care inaccessible or unproﬁtable. These are
strong incentives and can be a successful and sustainable addition to
a de-implementation process. However, policy changes could be dif-
ﬁcult to achieve. Other strategies for reducing ineffective care are
incorporation of do-not-do recommendations in clinical practice
guidelines and protocols or installing barriers or alerts in electronic
patient records when a low-value care practice is ordered. For
example, a study installed soft- and hard-stop computer alerts when
metformin was ordered inappropriately [25]. The key word for de-
implementing this kind of low-value care is ‘limit’.
‘Inefﬁcient care’ is caused by inefﬁcient organization and lack of
cooperation. Market withdrawal or exclusion from the beneﬁt pack-
age are not possible, since this care is in essence effective and still
needs to be delivered. A promising and sustainable strategy here lies
in hospitals or regional networks reorganizing care and facilitating
communication between healthcare providers. Duplication of
imaging for example might be solved by better information trans-
mission between electronic patient ﬁles. Another example is a study
that reduced the high intensity of routine laboratory tests by imple-
menting a new ordering system in which each test needs to be
ordered individually instead of in groups [26]. The key word for de-
implementing this kind of low-value care is ‘lean’.
Since ‘unwanted care’ depends on the preferences and values of
the patient, limiting or reorganizing care for all patients is not
appropriate. A promising strategy for reducing unwanted care is
facilitating shared-decision-making and sufﬁcient communication
between patient and caregiver. It is important that patients are well-
informed before making a decision and empowered to be more
involved in their healthcare, although this could be difﬁcult because
it requires time and skills from the caregiver. An example is a study
that reduced unwanted prostate cancer screening by providing
patients with a decision aid and educating physicians [27]. The key
word for de-implementing this kind of low-value care is ‘listen’.
Incorporating the reason for care to be of low-value in develop-
ing de-implementation strategies is important but not sufﬁcient.
Other contextual factors (e.g. local organizational structure, culture,
available time and money) play an important role and need to be
taken into account in a full-grown strategy. This means that facilita-
tors and barriers that either stimulate or impede wise choices need
to be tackled [28, 29]. The driving factors can be different for every
low-value care practice and can include fear of litigation, ﬁnancial
incentives, pressure from patients or lack of consultation time [30].
Low-value care
Ineffective care
E.g. essentially (cost)ineffective care or
(cost)ineffective care for a well-defined
subgroup
Limit
Inefficient care
E.g. inefficient provision or
inappropriate intensity
Lean
Unwanted care
E.g. care doesn't solve problem patient
or doesn't meet preferences patient
Listen
Figure 2 Typology of low-value care.
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Also, combining multiple strategies is generally more effective than a
single strategy [18]. Even when taking all these elements into
account, achieving sustainable change is hard and takes determin-
ation, time and money. This is a challenge we need to face in order
to reduce low-value care and improve healthcare.
Conclusion
We have developed a typology with three types of low-value care
related to their reason for being of low-value that describe the full
spectrum of low-value care according to our deﬁnition. Care can be
of low-value because it is ineffective, inefﬁcient and unwanted.
Recognition of these reasons may help to stimulate the debate on
how to reduce low-value care. Since for different types of low-value
care, different types of action may be the most promising target for
sustainable de-implementation, this typology may help in developing
a tailor-made strategy. Low-value care is an increasing problem in
western countries and there is an urge to take action. Reducing low-
value care increases the quality and safety of care and reduces costs,
and should be on the agenda in every country on policy, organiza-
tional and professional level. In addition, countries should focus on
preventing low-value care by investing in proper research and stric-
ter market authorization. We are positive that this typology will give
insight in low-value care and guide healthcare providers, policy
makers and researchers in the challenge of de-implementing low-
value care in many countries.
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